Search for any words: Search

                            

CALGB 100801 (Alliance): A phase II multi-center study of the addition of azacitidine (AZA) following allogeneic transplantation using a targeted busulfan based conditioning regimen for high risk myelodysplasia (MDS) and older patients with acute myeloid leukemia (AML)   

Vij, Ravi ,  Hars, Vera ,  Blum, William ,  Shore, Tsiporah ... -  EBMT   -  Bone Marrow Transplantation   -  2015    

Abstract -  Primary -  Primary -  Transplant -  CALGB-100801

Depth of Response to Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone Improves Over Time in Patients With Transplant-Eligible Newly Diagnosed Multiple Myeloma: GRIFFIN Study Update

Voorhees, Peter M ,  Kaufman, Jonathan L ,  Laubach, Jacob ... -  EBMT   -  Bone Marrow Transplantation   -  2020    

Abstract -  Secondary -  Primary -  Myeloma -  AFT-29